Showing the single result
-
Stem Cell Therapy for Neurological Disorders Market Size, Share, Trends, and Forecast (2025–2034): Industry Growth Analysis by Therapy Type (Autologous, Allogeneic), Cell Source (Adipose-Derived MSCs, Bone Marrow-Derived MSCs, Placental/Umbilical Cord-Derived MSCs, iPSCs, Neural Stem/Progenitor Cells), Application (Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Stroke & Spinal Cord Injury, ALS & Other Neurodegenerative Diseases), Delivery Method (Intracerebral/Intrathecal Injection, Intravenous Administration), End User (Hospitals & Specialty Clinics, Academic & Research Centers, CDMOs), Competitive Landscape, and Market Opportunities
Read more
